-
Protara Therapeutics (NASDAQ:TARA) Earns Outperform Rating from Analysts at Lifesci Capital
Source: Buzz FX / 12 Mar 2025 09:07:15 America/New_York
Protara Therapeutics (NASDAQ:TARA) Earns Outperform Rating from Analysts at Lifesci Capital Written by MarketBeat March 12, 2025 Share Link copied to clipboard. Remove Ads Stock analysts at Lifesci Capital began coverage on shares of Protar
Read more...